Use of pantoprazole for up to three years to prevent upper gastrointestinal events in patients receiving anticoagulant therapy with aspirin and/or rivaroxaban has a similar safety profile to placebo except for an increased risk for enteric infections.
Increasing vitamin K intake through dietary strategies improves the anticoagulation stability of warfarin-treated patients.
The burden of new-onset atrial fibrillation is considerable following TAVI and SAVR.
β-blockers can attenuate the impact of anger or stress on atrial fibrillation.
Low-risk patients with AF who take oral anticoagulants have a lower risk of dementia than those who do not use OAC.
Findings seen among young, healthy volunteers randomly assigned to energy drinks or placebo
Suboptimal blood pressure and fasting glucose levels are associated with atrioventricular block.
Investigators sought to determine whether the administration of PB2452, a specific reversal agent for ticagrelor, could reverse the antiplatelet effects of ticagrelor quickly and effectively.
An increased risk for stroke and SE was found among patients with newly diagnosed AF while receiving critical care compared with those without AF,
Future research needs to look at the role of antithrombotic therapy following percutaneous left atrial appendage closure.